The treatment of chronic progressive multiple sclerosis with cladribine.
A 2-year, placebo-controlled, double-blind, crossover study was started in 1992 to evaluate cladribine, an immunosuppressive drug, in the treatment of chronic progressive multiple sclerosis. In the first year patients were given cladribine 0.10 mg/kg per day for 7 days as four monthly courses for a...
I tiakina i:
| I whakaputaina i: | Proc Natl Acad Sci U S A |
|---|---|
| Ngā kaituhi matua: | , , , , , |
| Hōputu: | Artigo |
| Reo: | Inglês |
| I whakaputaina: |
National Academy of Sciences
1996
|
| Ngā marau: | |
| Urunga tuihono: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC40008/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/8643695/ https://ncbi.nlm.nih.govhttps://doi.org/10.1073/pnas.93.4.1716 |
| Ngā Tūtohu: |
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!
|